TFP
EXAS

Tilia Fiduciary Partners’s Exact Sciences EXAS Stock Holding History

Tilia Fiduciary Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-48
Closed -$4.51K – 217
2023
Q2 		$4.51K Hold
48
– – ﹤0.01% 445
2023
Q1 		$3.25K Hold
48
– – ﹤0.01% 455
2022
Q4 		$2.38K Hold
48
– – ﹤0.01% 457
2022
Q3 		$2K Hold
48
– – ﹤0.01% 478
2022
Q2 		$2K Hold
48
– – ﹤0.01% 492
2022
Q1 		$3K Hold
48
– – ﹤0.01% 494
2021
Q4 		$4K Buy
+48
New +$4.24K ﹤0.01% 495

Other funds holding EXAS

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Tilia Fiduciary Partners's EXAS Position: Q3 2023 in Review

Tilia Fiduciary Partners sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 48 shares — an estimated $4.51K sold.

Tilia Fiduciary Partners first reported a position in EXAS in Q4 2021 and held it in 7 quarters. The position peaked at $4.51K in Q2 2023. 625 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.

  • Tilia Fiduciary Partners reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
  • Tilia Fiduciary Partners sold 48 Exact Sciences shares in Q3 2023, an estimated $4.51K.
  • Tilia Fiduciary Partners first reported a position in Exact Sciences in Q4 2021 and held it in 7 quarters.
  • Tilia Fiduciary Partners's Exact Sciences position peaked at $4.51K in Q2 2023.
  • 625 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.

Based on Tilia Fiduciary Partners's 13F filing for Q3 2023, filed 10 Oct 2023.